1. Pinto-Leite R, Arantes-Rodrigues R, Sousa N, Oliveira PA, Santos L: mTOR inhibitors in urinary bladder cancer. (1423–0380 (Electronic)).
2. Fujii Y: Prediction models for progression of non-muscle-invasive bladder cancer: A review. (1442–2042 (Electronic)).
3. Kobayashi T: Understanding the biology of urothelial cancer metastasis. (2214–3882 (Print)).
4. Hafeez S, Horwich A, Omar O, Mohammed K, Thompson A, Kumar P, Khoo V, Van As N, Eeles R, Dearnaley D et al: Selective organ preservation with neo-adjuvant chemotherapy for the treatment of muscle invasive transitional cell carcinoma of the bladder. (1532–1827 (Electronic)).
5. Stenzl A, Cowan Nc Fau - De Santis M, De Santis M Fau - Kuczyk MA, Kuczyk Ma Fau - Merseburger AS, Merseburger As Fau - Ribal MJ, Ribal Mj Fau - Sherif A, Sherif A Fau - Witjes JA, Witjes JA: Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelines. (1873–7560 (Electronic)).